PL90397B1 - - Google Patents
Download PDFInfo
- Publication number
- PL90397B1 PL90397B1 PL1973164708A PL16470873A PL90397B1 PL 90397 B1 PL90397 B1 PL 90397B1 PL 1973164708 A PL1973164708 A PL 1973164708A PL 16470873 A PL16470873 A PL 16470873A PL 90397 B1 PL90397 B1 PL 90397B1
- Authority
- PL
- Poland
- Prior art keywords
- water
- general formula
- acid
- compound
- solvent
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 9
- 150000007513 acids Chemical class 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- -1 inorganic acid halides Chemical class 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 150000007529 inorganic bases Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Chemical class 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 241000700159 Rattus Species 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 239000005995 Aluminium silicate Substances 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 229960002895 phenylbutazone Drugs 0.000 description 3
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- KXLUFTQIVRWULN-UHFFFAOYSA-N 4-[4-(2-fluorophenyl)phenyl]but-3-enoic acid Chemical compound FC1=C(C=CC=C1)C1=CC=C(C=C1)C=CCC(=O)O KXLUFTQIVRWULN-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011591 potassium Chemical class 0.000 description 2
- 229910052700 potassium Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N 2-butenoic acid Chemical compound CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- XQKLFJUJTVMQBF-UHFFFAOYSA-N CCOC(CC(C)(C(C=C1)=CC=C1C(C=CC=C1)=C1Cl)O)=O Chemical compound CCOC(CC(C)(C(C=C1)=CC=C1C(C=CC=C1)=C1Cl)O)=O XQKLFJUJTVMQBF-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical class Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000003946 cyclohexylamines Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
- C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/20—Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms
- C07C17/202—Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms two or more compounds being involved in the reaction
- C07C17/208—Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms two or more compounds being involved in the reaction the other compound being MX
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych pochodnych bifenylowych, o wartos¬ ciowych wlasciwosciach farmakologicznych, zwla¬ szcza o dzialaniu przeciwzapaleniowym. Stanowia one poza tym produkty posrednie do wytwarzania dzialajacych przeciwzapaleniowo kwasów 3-/4-taife- nylilo/jmaslowych i ich [pochodnych.Nowym zwiazkom odpowiada wzór ogólny 1, w którym Rj oznacza atom fluoru lub chloru, a B oznacza grupe hydroksylowa lub alkoksylowa.Wedlug wynalazku zwiazki o wzorze ogólnym 1 wytwarza sie przez odszczepienie wody ze zwiazku o wzorze ogólnym 2, w którym Rt i B maja wyzej podane znaczenie.Reakcja zachodzi w obecnosci srodka odszcze- piajacego wode, zwlaszcza w obecnosci obojetnego rozpuszczalnika, nie mieszajacego sie z woda, ko¬ rzystnie za pomoca polaczonego posrednio oddzie¬ lacza wody, w temperaturze do temperatury wrze¬ nia stosowanego rozpuszczalnika.Jako srodek odszczepiajacy wode stosuje sie re¬ agujaca kwasno sól, np. sole pirydyny lub alkilo- pirydyny z kwasami chlorowcowodorowymi, wo- dorosiarczkiem potasu, ale równiez sole metali, jak chlorek cynku, kwasy, jak kwas p-toluenosulfono- wy, fosforowy, siarkowy lub w przypadku gdy B oznacza grupe alkoksylowa, stosuje sie przede wszystkim nieorganiczne halogenki kwasowe, np. tlenohalogenek fosforu. Jako obojetne rozpuszczal¬ niki stosuje sie, np. benzen, toluen, lub ksylen, mozna jednak reakcje prowadzic w nieobecnosci rozpuszczalnika.Jezeli otrzymuje sie zwiazek o wzorze ogólnym 1, w którym B oznacza grupe alkoksylowa, to mozna je ewentualnie przeprowadzic przez zmydle- nie, np. lugiem metalu alkalicznego w kwasy (B= grupa hydroksylowa) lub w ich sole o wzorze ogól¬ nym 1. Z otrzymanych soli mozna ewentualnie uwolnic kwasy przez zakwaszenie kwasem mine¬ ralnym! Zmydlenie mozna prowadzic równiez moc¬ nym kwasem, np. kwasem mineralnym.Jezeli w wyzej opisanym sposobie otrzymuje sie kwas o wzorze ogólnym 1 (;B oznacza grupe hy¬ droksylowa), to mozna go przeprowadzic ewentual¬ nie w ester, w znany sposób.Kwasy o wzorze ogólnym 1, w którym B oznacza grupe hydroksylowa, mozna ewentualnie przepro¬ wadzic w sole np. z nieorganicznymi lub organicz¬ nymi zasadami. Jako organiczne zasady stosuje sie szczególnie dwuetanoloamine, morfoline, cyklohek- syloamine ipiperazyne.Stosowane jako produkty wyjsciowe zwiazki o wzorze ogólnym 2 otrzymuje sie przez reakcje ke¬ tonu o wzorze ogólnym 3, w którym Rj ma wyzej podane znaczenie, z zwiazkiem cynku estru kwasu chlorowcooctowego. Reakcja zachodzi w organicz¬ nym rozpuszczalniku, np. w eterze, jak eter ety¬ lowy, dwumetoksyetan, dwuetoksyetan, dioksan, czterowodorofuran lub w mieszaninach tych roz¬ puszczalników lub w obojetnym rozpuszczalniku, 90 39790 397 takim jak benzen lub toluen, w temperaturze 15— —1I20^C, zwlaszcza 20^60°C.Ketony o ogólnym wzorze 3 mozna wytwarzac latwo z odpowiednio podstawionych bifenyli, przez reakcje z chlorkiem acetylu w obecnosci bezwodne¬ go chlorki* glinu.Nowe zwiazki o wzorze ogólnym 1 wykazuja szczególnie wartosciowe wlasciwosci farmakologicz- lie, zwlaszcza bardzo dobre dzialanie przeciwzapa- leniowe. *v Nowe zwiazki o wzorze ogólnym 1 mozna prze¬ rabiac do farmaceutycznego stosowania ewentual¬ nie w mieszaninie z innymi substancjami czynny¬ mi o wzorze ogólnym 1 na zwykle uzywane 'pre¬ paraty. Dawka jednostkowa wynosi 50—400 mg, korzystnie 100—300 mg. dawka dzienna 100—1000 mg, korzystnie 150-^600 mg.Nastepujaca substancje poddano badaniom na jej bezwzgledne dzialanie przeciwzapaleniowe i jej toksycznosc: .¦*'¦¦ - A=kwas 3-/2'-cfluoro-4-bifenylilo/-propenokarboksy- -lowy i jako, substancje porównawcza fenylobuta- zon. Zdolnosc tlumienia stanów zapalnych wywo¬ lanych w tylnej lapie szczura za pomoca kaolinu lub za pomoca lichen carragen (mech islandzki) obrzeku przeprowadzono pomiary jak w próbie ka- , olinowej. c) Ostra toksycznosc. Ostra toksycznosc LD5fl oznaczono podajac jednakowej liczbie samców i sa¬ mic szczura FW 49 o przecietnej wadze 135 g badane substancje zmieszane z tyloza. Wartosc LD50 oznaczono w miare mozliwosci metoda Licht- field'a i Wilcozon'a na podstawie liczby zwierzat, które po róznych dawkach padly w ciagu 14 dni. d) Wskaznik terapeutyczny stanowiacy miare za¬ kresu terapeutycznego oznaczono jako stosunek wartosci LD50 przy podawaniu doustnym szczurom badanej substancji, do sredniej wartosci LD35 usta¬ lonej w badaniu zdolnosci przeciwdzialania sta¬ nom zapalnym, wywolanym u szczura metoda ka¬ olinowa i karragenowa.Uzyskane w tych 'badaniach wyniki podane sa w nastepujacej tablicy.Poddawany badaniom zwiazek przewyzsza znany fenylobutazon w pozadanym dzialaniu przeciwza- paleniowym.Poniewaz toksycznosc nie wzrasta równolegle z wzrostem dzialania przeciwzapaleniowego, badany zwiazek przewyzsza swym wskaznikiem terape¬ utycznym znany fenylobutazon 'bardzo wydatnie.Substancje Fenylobutazon A Obrzek kaolinowy LD35 — por os mg/kg 58 9,5 Obrzek karrageninowy ED35 per os mg/kg €9 9,3 Srednia wartosc ED35 mg/kg 63,5 9,6 Ostra toksycznosc LD50 mg/kg 864 49,5 Wskaznik terepeutyczny stosunek toksycznego do dzialania LD5o/ED35 13,6 , 51,7 oraz ich estra toksycznosc badano na szczurach po podaniu doustnie badanej substancji. a) Obrzek na tylnej lapie szczura wywolany ka¬ olinem. Obrzek wywolano metoda Hillebrechta [Arzneimittel-Forsch. 4, 607 /1954/] przez wstrzy¬ kiwanie pod podeszwe lapy szczura 0,05 nu\ 10% zawiesiny kaolinu w 0,85% roztworze chlorku sodu.Pomiary grubosci lapy prowadzono metoda Doepfnera i Cerletti'ego [Int. Arch. Allergy Im- mumol. 12, 89 yil95fl/].Samcom szcziurów PW 49 o wadze 120—150 g podawano badane substancje za pomoca zglebnika przelykowo-zoladkowego na 30 minut przed spo¬ wodowaniem obrzeku. Po uplywie 5 godzin od wywolania obrzeku mierzono wielkosc opuchlizny, porównujac ja z odpowiednia wielkoscia u zwie¬ rzat, którym nie podano badanej substancji. Na drodze graficznej ekstrapolacji z otrzymanych z róznych dawek procentowych wartosci hamowania opuchlizny, ustalono dawke prowadzaca do 35% zmniejszenia opuchlizny /ED35/. b) Obrzek karragenowy. Obrzek wywolywano metoda Wintera i inn. /Proc. Soc. exp. Biel. Mod. 111, 544 /1902// przez wstrzykiwanie pod podeszwe lapy szczura 0,05 ml 1% roztworu mchu islandz¬ kiego w 0,05% roztworze NaCl. Badane substancje podawano szczurom na 60 m!nut przed wywola¬ niem obrzeku. Po uplywie 3 godzin od wywolania 40 45 50 55 60 65 Przyklad I. Kwas 3-/2'-fluoro-4^bifenyiilo/- -2-propenokarboksylowy 4,5 g /0,Q15 mola/ estru etylowego kwasu 3-/2'- fluoro-4-bifenylilo/-3-hydroksymaslowego /tempera¬ tura topnienia 71—73°C/ rozpuszcza sie w 75 ml benzenu i ogrzewa pod chlodnica zwrotna przez minut z 3,5 g A),0225 mola/ tlenochlorku fosforu.Nastepnie odparowuje sie w prózni rozpuszczalnik, pozostalosc zadaje woda z lodem i ekstrahuje ete¬ rem. Z roztworu eterowego, wytrzasanego z woda oddestylowuje sie rozpuszczalnik. Krystaliczna po¬ zostalosc przekrystalizowuje sie z estru naftowego.Otrzymany ester etylowy kwasu 3T/2'-fluoro-4- ^bifenylilo/-2-propenokarboksylowego/ na podstawie widma rezonansu jadrowego postac — trans/, top¬ nieje w temperaturze 53°C.Wydajnosc wynosi 4,1 g /96% wydajnosci teoretycz¬ nej/.Roztwór 4,1 g estru etylowego kwasu 3-/2'-flu- oro^4-bilfenylilo/-2-propenokarboksylowego ogrzewa sie przez 2 godziny pod chlodnica zwrotna w me¬ tanolu z 10 ml 30% lugu potasowego, po czym od¬ destylowuje metanol, dodaje 200 ml wody i zakwa¬ sza 15% kwasem solnym. Utworzony osad rozpusz¬ cza w eterze, suszy nad siarczanem sodu i odparo¬ wuje eter. Pozostalosc przekrystalizowuje sie z octanu etylowego.Otrzymuje sie 2,8 g /76% wydajnosci teoretycz¬ nej kwasu S-^-fluoro^bifenyttloM-propenoksy-90 397 karboksylowego, o temperaturze topnienia 177— ^170°C.Wytracona z acetonu sól cykloheksyloaminowa topnieje w temperaturze 194—1&5°C.Przyklad II. Kwas 3-/2'^fluoro-4-bifenylilo/- -2-propenokarboksylowy g /0,0547 mola/ kwasu 3-/'2'-fluoro-4-bifeny- lilo/-3-hydroksymaslowego /temperatura topnienia 108—110%/ ogrzewa sie w 150 ml toluenu z 1 g kwasu p-toluenosulfonowego, podczas mieszania, pod chlodnica zwrotna w naczyniu polaczonym po¬ srednio z oddzielaczem wody, przez 1 godzine.Po oziejbieniu dodaje sie 100 ml octanu etylu, przemywa organiczny roztwór woda i odparowuje rozpuszczalnik. Pozostalosc przekrystalizowuje sie z octanem etylu.Otrzymuje sie 8 g kwasu 3-/2'-fluoro-4-bifenyli- lo/-2-propenokarboksylowego, o temperaturze top¬ nienia 177^178°C. ifenylilo/- -2-propenokarboksylowy Ogrzewa sie 96 g /0,3 mola/ surowego estru ety¬ lowego kwasu 3-/2'-chloro-4-bifenyliló/-3-hydroksy- maslowego w 500 ml benzenu z 67 g 70,44 mola/ tlenotrójchlorku fosforu przez 10 minut pod chlod¬ nica zwrotna, po czym oddestylowuje rozpuszczal¬ nik, pozostalosc zadaje woda i wydzielony olej ekstrahuje eterem. Po przemyciu do odczynu obo¬ jetnego woda i 5% roztworem wodoroweglanu sodu, roztwór eterowy suszy sie i saczy przez wegiel aktywny, a nastepnie odestylowuje rozpuszczalnik.Pozostalosc krystalizuje sie z eteru naftowego, przy czym otrzymuje sie 71,5 g /79,5°/o wydajnosci te¬ oretycznej/ estru etylowego kwasu 3-/2'-chloro-4- -bifenylilo/-2-propenokarboksylowego, o tempera¬ turze topnienia 77—80°C.Przez zmydlenie estru za pomoca 30°/* etanolo- wego roztworu wodorotlenku sodowego otrzymuje sie kwas 3-/2'-chloro-4-bifenylilo/^2-propenokaffbo- ksylowy, o temperaturze topnienia 168—169qC /z etanolu/. PL
Claims (2)
- Zastrzezenia patentowe 1. Sposób wytwarzania nowych pochodnych bife- nylowych o wzorze ogólnym 1, w którym Rj ozna¬ cza atom fluoru lub chloru, a B oznacza grupe hy- 15 droksyIowa lub alkoksylowa, znamienny tym, ze ze zwiazku o wzorze ogólnym 2, w którym Rj i B maja wyzej podane znaczenie, odszczepia sie wode za pomoca srodka odszczepiajacego wode i w przy¬ padku gdy w produkcje reakcji B oznacza grupe 20 alkoksylowa, produkt ten ewentualnie poddaje sie zmydleniu i otrzymany zwiazek o wzorze ogólnym 1, w którym B oznacza grupe hydroksylowa, ewen-# tualnie przeprowadza w fizjologicznie dopuszczalna sól z nieorganiczna lub organiczna zasada lub 25 ewentualnie przeprowadza w znany sposób w ester.
- 2. Sposób wedlug zastrz. 1, znamienny tym, ze jako srodek odszczepiajacy wode stosuje sie kwasno reagujace sole, sole metali, odciagajace wode kwa¬ sy lub nieorganiczne halogenki kwasowe. 30 3: Sposób wedlug zastrz. 1, znamienny tym, ze reakcje prowadzi sie w obojetnym niemieszajacym sie z woda rozpuszczalniku, korzystnie stosujac od¬ dzielacz wody, w temperaturze do temperatury wrzenia stosowanego rozpuszczalnika.90 397 CH3 / W VA=rM- C=CH-COB WZdR 1 WZdR 2 BliU 27f'./77 i\ 110 <:;;'. Al Cena 10 zl PL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2240441A DE2240441A1 (de) | 1972-08-17 | 1972-08-17 | Neue biphenylderivate und verfahren zur herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
PL90397B1 true PL90397B1 (pl) | 1977-01-31 |
Family
ID=5853790
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1973164708A PL90397B1 (pl) | 1972-08-17 | 1973-08-16 | |
PL1973186474A PL94510B1 (pl) | 1972-08-17 | 1973-08-16 | Sposob wytwarzania nowych amidow kwasu 3-(4-bifenylilo)-2-propenokarboksylowego |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1973186474A PL94510B1 (pl) | 1972-08-17 | 1973-08-16 | Sposob wytwarzania nowych amidow kwasu 3-(4-bifenylilo)-2-propenokarboksylowego |
Country Status (19)
Country | Link |
---|---|
JP (2) | JPS49124051A (pl) |
AT (3) | AT328427B (pl) |
AU (2) | AU5930873A (pl) |
BE (3) | BE803734A (pl) |
BG (3) | BG21844A3 (pl) |
CH (1) | CH588435A5 (pl) |
CS (3) | CS165386B2 (pl) |
DD (2) | DD108071A5 (pl) |
DE (1) | DE2240441A1 (pl) |
ES (4) | ES417884A1 (pl) |
FR (2) | FR2196167B1 (pl) |
GB (2) | GB1410852A (pl) |
HU (2) | HU166516B (pl) |
IL (2) | IL43004A0 (pl) |
NL (2) | NL7311301A (pl) |
PL (2) | PL90397B1 (pl) |
RO (2) | RO62918A (pl) |
SU (11) | SU484679A3 (pl) |
ZA (3) | ZA735628B (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2457275A1 (fr) * | 1979-05-21 | 1980-12-19 | Fabre Sa Pierre | Acides p-biphenyl-4 methyl-2 buten-3 oiques utiles dans le traitement des rhumatismes |
RU2686489C1 (ru) * | 2018-12-27 | 2019-04-29 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет (СПбГУ)" | Способ получения α-диазокарбонильных соединений в водной среде |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2128277B2 (pl) * | 1970-05-05 | 1979-06-22 | Rorer Inc William H | |
BE776316R (fr) * | 1971-03-10 | 1972-06-06 | Rorer Inc William H | Nouveaux derives d'acides phenyl-acetiques substitues et procede pour leur |
-
1972
- 1972-08-17 DE DE2240441A patent/DE2240441A1/de active Pending
-
1973
- 1973-08-14 AT AT711273A patent/AT328427B/de not_active IP Right Cessation
- 1973-08-14 AT AT710773A patent/AT323143B/de not_active IP Right Cessation
- 1973-08-14 ES ES417884A patent/ES417884A1/es not_active Expired
- 1973-08-14 AT AT710873A patent/AT323144B/de not_active IP Right Cessation
- 1973-08-14 CH CH1170773A patent/CH588435A5/xx not_active IP Right Cessation
- 1973-08-14 ES ES417883A patent/ES417883A1/es not_active Expired
- 1973-08-15 BG BG27671A patent/BG21844A3/xx unknown
- 1973-08-15 DD DD172906A patent/DD108071A5/xx unknown
- 1973-08-15 SU SU1958288A patent/SU484679A3/ru active
- 1973-08-15 BG BG24328A patent/BG22069A3/xx not_active Expired
- 1973-08-15 SU SU1958290A patent/SU511846A3/ru active
- 1973-08-15 HU HUTO925A patent/HU166516B/hu unknown
- 1973-08-15 BG BG24327A patent/BG21197A3/xx unknown
- 1973-08-15 DD DD172907A patent/DD107901A5/xx unknown
- 1973-08-15 SU SU1958291A patent/SU482039A3/ru active
- 1973-08-15 HU HUTO926A patent/HU166517B/hu unknown
- 1973-08-16 ZA ZA00735628A patent/ZA735628B/xx unknown
- 1973-08-16 CS CS4903A patent/CS165386B2/cs unknown
- 1973-08-16 AU AU59308/73A patent/AU5930873A/en not_active Expired
- 1973-08-16 GB GB3884473A patent/GB1410852A/en not_active Expired
- 1973-08-16 CS CS4904A patent/CS165387B2/cs unknown
- 1973-08-16 ZA ZA00735629A patent/ZA735629B/xx unknown
- 1973-08-16 PL PL1973164708A patent/PL90397B1/pl unknown
- 1973-08-16 CS CS5793A patent/CS165385B2/cs unknown
- 1973-08-16 NL NL7311301A patent/NL7311301A/xx unknown
- 1973-08-16 GB GB3884373A patent/GB1411495A/en not_active Expired
- 1973-08-16 PL PL1973186474A patent/PL94510B1/pl unknown
- 1973-08-16 JP JP48092052A patent/JPS49124051A/ja active Pending
- 1973-08-16 NL NL7311300A patent/NL7311300A/xx unknown
- 1973-08-16 ZA ZA00735616A patent/ZA735616B/xx unknown
- 1973-08-16 AU AU59309/73A patent/AU476340B2/en not_active Expired
- 1973-08-16 JP JP48092053A patent/JPS49124052A/ja active Pending
- 1973-08-16 IL IL43004A patent/IL43004A0/xx unknown
- 1973-08-16 IL IL43003A patent/IL43003A0/xx unknown
- 1973-08-17 FR FR7330075A patent/FR2196167B1/fr not_active Expired
- 1973-08-17 BE BE134691A patent/BE803734A/xx unknown
- 1973-08-17 RO RO7300075822A patent/RO62918A/ro unknown
- 1973-08-17 BE BE134689A patent/BE803732A/xx unknown
- 1973-08-17 BE BE134690A patent/BE803733A/xx unknown
- 1973-08-17 FR FR7330076A patent/FR2196168B1/fr not_active Expired
- 1973-08-17 RO RO7300075821A patent/RO62917A/ro unknown
-
1974
- 1974-10-21 SU SU2069110A patent/SU554810A3/ru active
- 1974-10-21 SU SU2069576A patent/SU561505A3/ru active
- 1974-10-21 SU SU7402069575A patent/SU577967A3/ru active
- 1974-10-21 SU SU2069578A patent/SU511847A3/ru active
- 1974-10-21 SU SU2069577A patent/SU520907A3/ru active
- 1974-10-21 SU SU2069774A patent/SU552021A3/ru active
- 1974-10-21 SU SU2069114A patent/SU538658A3/ru active
- 1974-10-21 SU SU2069771A patent/SU520030A3/ru active
- 1974-11-30 ES ES432464A patent/ES432464A1/es not_active Expired
- 1974-11-30 ES ES432465A patent/ES432465A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4008323A (en) | Method of reducing cholesterol using certain aromatic keto acids | |
DD156260A1 (de) | Herstellung von imidazolderivaten | |
NO743186L (pl) | ||
DK143552B (da) | Analogifremgangsmaade til fremstilling af substituerede phenyleddikesyrederivater | |
EP0064027B1 (de) | Neue Benzodioxolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE2531456A1 (de) | Antiinflammatorisch und analgetisch wirksame stilbenderivate | |
US3553234A (en) | Dibenzo(d,g)(1,3)dioxocin-6-carboxylic acids, esters and salts | |
PL90397B1 (pl) | ||
PL84351B1 (pl) | ||
EP0169571B1 (de) | Phenylnonatetraensäurederivate, ihre Herstellung und pharmazeutische Präparate mit diesen Derivaten | |
NO131930B (pl) | ||
EP0592664A1 (en) | Novel diphenylthyazole derivative | |
CS223875B2 (en) | Method of making the compounds similar to the dilignolum | |
US3112337A (en) | 4-halo-3-sulfamoylbenzoic acid esters | |
US3594388A (en) | 4-amino-5-(substituted phenyl) furazan | |
US4002629A (en) | Certain pyridine carboxamide derivatives | |
US4137323A (en) | Organic compounds | |
DE3641907A1 (de) | 4h-benzo(4,5)cyclohepta(1,2-b)thiophen derivate | |
US3985788A (en) | Phenyl propionic acids and derivatives thereof | |
US4354033A (en) | Anthranilic acid esters | |
US3812135A (en) | Pyrroloindole and pyridoindole derivatives | |
US3032557A (en) | New 4-hydroxycoumarin derivatives and processes for the preparation thereof | |
US3400130A (en) | Subistituted delta8-octahydroquinoline-2, 7-diones and their 7-alkylene thioketals | |
PL91487B1 (pl) | ||
US3285919A (en) | Piperazinyl alkyl thiaxanthene derivatives |